, 2011). There is presently no detailed analysis in the efficacy and security of avatrombopag in individuals with thrombocytopenia. On this analyze, a pc-centered lookup was utilized to retrieve randomized, double-blind scientific trials involving individuals with thrombocytopenia as well as relevant data have been extracted to permit an proof-base